跳至主要内容
临床试验/NCT04994704
NCT04994704已完成不适用

Comparison of Postoperative Quality of Recovery (QoR)-15 Scores According to the Use of Anesthetics (Propofol vs. Remimazolam) During Total Intravenous Anesthesia in the Spine Surgery Patients

Gangnam Severance Hospital1 个研究点 分布在 1 个国家目标入组 73 人开始时间: 2021年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
73
试验地点
1
主要终点
The difference of QoR-15 scores between two groups (propofol vs. remimazolam)

研究概览

简要总结

Remimazolam is a ultra-short-acting benzodiazepine, and unlike conventional benzodiazepine drugs, it is rapidly metabolized in plasma and not accumulates in the body for long periods of infusion or even with high dose administration. In addition, it has no injection pain and infusion syndrome compared with propofol. In particular, there is no study to investigate overall postoperative functional recovery via QoR-15 in patients receiving TIVA using remimazolam. Therefore, rhe purpose of the study is to compare poetoperative quality of recovery (QoR)-15 scores according to the use of anesthetics for total intravenous anesthesia in the cervical spine surgery with intraoperative neurophysiological monitoring.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients who aged 20-70 years with ASA-PS 1-3,
  • diagnosed of ossification of the posterior longitudinal ligament or cervical spondylotic myelopathy
  • intraoperative neurophysiological monitoring.

排除标准

  • Tolerance or hypersensitivity to benzodiazepine or propofol
  • Dependence or addiction to psychotropic drugs or alcohol
  • Pregnant women, subjects who lack the ability to make decisions and susceptible to voluntary participation decisions

研究组 & 干预措施

Propofol group

Experimental

Propofol based total intravenous anesthesia

干预措施: Propfol group (Drug)

Remimazolam group

Active Comparator

Remimazolam based total intravenous anesthesia

干预措施: Remimazolam group (Drug)

结局指标

主要结局

The difference of QoR-15 scores between two groups (propofol vs. remimazolam)

时间窗: postoperative day 1

The difference of scores in the Quality of Recovery (QoR)-15 survey.Minimum value: 0, Maximum value: 150, higher scores means better.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dong Woo Han

Professor

Gangnam Severance Hospital

研究点 (1)

Loading locations...

相似试验